MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image SENTI BIOSCIENCES
SENTI BIOSCIENCES

SENTI BIOSCIENCES

Summary

Senti Biosciences is a developer of a programmable biology platform for cancer therapies.

Deals Overview

Total Deals3
Valued Deals3
Total Value£ 561 M
Avg. Deal Size£ 187 M

Market Context

Sort

06 Jan 2021|United States|Biotechnology
Senti Biosciences
8vc (eight Partners Llc)

Target: SENTI BIOSCIENCES

Bidder: 8VC (EIGHT PARTNERS LLC)

11 Service Providers

2 Target | 9 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 77 M

Value

20 Dec 2021|United States|Biotechnology
Senti Biosciences
Dynamics Special Purpose Corporation

Target: SENTI BIOSCIENCES

Bidder: DYNAMICS SPECIAL PURPOSE CORPORATION

17 Service Providers

3 Target | 14 Bidder

42 Dealmakers

18 Target | 24 Bidder

£ 453 M

Value

10 Aug 2023|United States|Pharmaceuticals
Senti Bio (chemistry, Manufacturing, And Controls)
Genefab

Target: SENTI BIO (CHEMISTRY, MANUFACTURING, AND CONTROLS)

Bidder: GENEFAB LLC

7 Service Providers

4 Bidder | 3 Vendor

18 Dealmakers

5 Bidder | 13 Vendor

£ 29 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite